MetaADEDB 2.0 @ LMMD
Clopidogrel
(FDEODCTUSIWGLK-RSAXXLAASA-N)
Structure
SMILES
OS(=O)(=O)O.COC(=O)[C@H](c1ccccc1Cl)N1CCc2c(C1)ccs2
Molecular Formula:
C16H18ClNO6S2
Molecular Weight:
419.900
Log P:
4.0398
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
140.76
CAS Number(s):
120202-66-6; 135046-48-9; 144077-07-6
Synonym(s)
1.
Clopidogrel
2.
Clopidogrel Besilate
3.
Clopidogrel Besylate
4.
Clopidogrel Bisulfate
5.
Clopidogrel Hydrochloride
6.
Clopidogrel Napadisilate
7.
Clopidogrel Sandoz
8.
Clopidogrel, (+)(S)-isomer
9.
Clopidogrel-Mepha
10.
Iscover
11.
PCR 4099
12.
PCR-4099
13.
Plavix
14.
SC 25989C
15.
SC 25990C
16.
SR 25989
17.
Clopidogrel Mepha
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Cerebrovascular accidentFAERS: 332
Canada Vigilance: 7
Canada Vigilance
US FAERS
2Myocardial InfarctionFAERS: 292
Canada Vigilance: 3
Canada Vigilance
US FAERS
3PainFAERS: 220
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 163
Canada Vigilance: 6
Canada Vigilance
US FAERS
5Physical disabilityFAERS: 157US FAERS
6ThrombosisFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
7AnhedoniaFAERS: 98US FAERS
8AstheniaFAERS: 98
Canada Vigilance: 1
Canada Vigilance
US FAERS
9TensionFAERS: 95US FAERS
10Economic problemFAERS: 91US FAERS
11DizzinessFAERS: 89
Canada Vigilance: 2
Canada Vigilance
US FAERS
12Psychological TraumaFAERS: 87US FAERS
13DeformityFAERS: 84US FAERS
14HeadacheFAERS: 80US FAERS
15Atrial FibrillationFAERS: 79US FAERS
16EpistaxisFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Chest PainFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
18FatigueFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
19PneumoniaFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
20PruritusFAERS: 69
Canada Vigilance: 3
Canada Vigilance
US FAERS
21NauseaFAERS: 65US FAERS
22MalaiseFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
23ArthralgiaFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
24UrticariaFAERS: 43
Canada Vigilance: 5
Canada Vigilance
US FAERS
25VomitingFAERS: 43US FAERS
26Weight decreasedFAERS: 42US FAERS
27Deep Vein ThrombosisFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
28ThrombocytopeniaFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
29OverdoseFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
30Product quality issueFAERS: 38US FAERS
31Feeling abnormalFAERS: 37US FAERS
32Back PainFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Unevaluable eventFAERS: 34US FAERS
34MyalgiaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
35SepsisFAERS: 33US FAERS
36AmnesiaFAERS: 31US FAERS
37BlindnessFAERS: 31US FAERS
38Thrombosis in deviceFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Adverse eventFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
40HypersensitivityFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Vascular occlusionFAERS: 29US FAERS
42Drug resistanceFAERS: 27US FAERS
43Pulmonary EmbolismFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
44SyncopeFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Visual ImpairmentFAERS: 27US FAERS
46Gastric ulcerFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
47RhabdomyolysisFAERS: 26US FAERS
48Chest discomfortFAERS: 25US FAERS
49Abdominal PainFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Drug dose omissionFAERS: 23US FAERS
51HypotensionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Respiratory FailureFAERS: 23US FAERS
53Abdominal discomfortFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Angina PectorisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Cardiac ArrestFAERS: 21US FAERS
56Gastrointestinal ulcerFAERS: 21US FAERS
57Macular degenerationFAERS: 21US FAERS
58DementiaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
59DysgeusiaFAERS: 20US FAERS
60UlcerFAERS: 20US FAERS
61Urinary tract infectionFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
62jaundiceFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
63DyspepsiaFAERS: 19US FAERS
64ArthropathyFAERS: 18US FAERS
65PurpuraFAERS: 18US FAERS
66ErythemaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
67HemiplegiaFAERS: 17US FAERS
68Stent occlusionFAERS: 17US FAERS
69Coronary Artery DiseaseFAERS: 16US FAERS
70GastritisFAERS: 16US FAERS
71General physical health deteriorationFAERS: 16US FAERS
72SwellingFAERS: 16US FAERS
73AphasiaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
74Cerebral InfarctionFAERS: 15US FAERS
75No adverse eventFAERS: 15US FAERS
76Product substitution issueFAERS: 15US FAERS
77AbasiaFAERS: 14US FAERS
78AnxietyFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
79BradycardiaFAERS: 14US FAERS
80Diabetes MellitusFAERS: 14US FAERS
81PhlebitisFAERS: 14US FAERS
82ConstipationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
83In-stent coronary artery restenosisFAERS: 13US FAERS
84NeutropeniaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
85PancytopeniaFAERS: 13US FAERS
86PetechiaeFAERS: 13US FAERS
87TremorFAERS: 13US FAERS
88Wrong technique in drug usage processFAERS: 13US FAERS
89Acute myocardial infarctionFAERS: 12US FAERS
90Alanine Aminotransferase IncreasedFAERS: 12US FAERS
91Aspartate Aminotransferase IncreasedFAERS: 12US FAERS
92LeukopeniaFAERS: 12US FAERS
93MYELODYSPLASTIC SYNDROMEFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Medication ErrorFAERS: 12US FAERS
95Memory impairmentFAERS: 12US FAERS
96Product counterfeitFAERS: 12US FAERS
97Product taste abnormalFAERS: 12US FAERS
98Suspected counterfeit productFAERS: 12US FAERS
99Urinary RetentionFAERS: 12US FAERS
100White blood cell count decreasedFAERS: 12US FAERS
101AgeusiaFAERS: 11US FAERS
102AneurysmFAERS: 11US FAERS
103Arterial restenosisFAERS: 11US FAERS
104ArthritisFAERS: 11US FAERS
105Burning sensationFAERS: 11US FAERS
106Carotid artery occlusionFAERS: 11US FAERS
107ChillsFAERS: 11US FAERS
108DisabilityFAERS: 11US FAERS
109DysarthriaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Emotional distressFAERS: 11US FAERS
111Increased tendency to bruiseFAERS: 11US FAERS
112Neck PainFAERS: 11US FAERS
113SomnolenceFAERS: 11US FAERS
114Acute Coronary SyndromeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
115AgranulocytosisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Altered state of consciousnessFAERS: 10US FAERS
117Blood urine presentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Device occlusionFAERS: 10US FAERS
119Disseminated Intravascular CoagulationFAERS: 10US FAERS
120HemiparesisFAERS: 10US FAERS
121In-stent arterial restenosisFAERS: 10US FAERS
122Musculoskeletal PainFAERS: 10US FAERS
123Skin UlcerFAERS: 10US FAERS
124Thrombocytopenic purpuraFAERS: 10US FAERS
125Blood creatine phosphokinase increasedFAERS: 9US FAERS
126Cardiac DeathFAERS: 9US FAERS
127Depressed Level of ConsciousnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
128DisorientationFAERS: 9US FAERS
129DiverticulitisFAERS: 9US FAERS
130EmbolismFAERS: 9US FAERS
131Intracranial AneurysmFAERS: 9US FAERS
132Joint swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
133LethargyFAERS: 9US FAERS
134Lip swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Oropharyngeal painFAERS: 9US FAERS
136PancreatitisFAERS: 9US FAERS
137Pulmonary FibrosisFAERS: 9US FAERS
138Aortic AneurysmFAERS: 8US FAERS
139Blood creatinine increasedFAERS: 8US FAERS
140ChromaturiaFAERS: 8US FAERS
141DeafnessFAERS: 8US FAERS
142DehydrationFAERS: 8US FAERS
143Drug exposure during pregnancyFAERS: 8US FAERS
144EcchymosisFAERS: 8US FAERS
145Gene MutationFAERS: 8US FAERS
146InfarctionFAERS: 8US FAERS
147InfluenzaFAERS: 8US FAERS
148Insulin autoimmune syndromeFAERS: 8US FAERS
149Musculoskeletal stiffnessFAERS: 8US FAERS
150Ocular icterusFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Pharmaceutical product complaintFAERS: 8US FAERS
152Platelet function test abnormalFAERS: 8US FAERS
153Retinal DetachmentFAERS: 8US FAERS
154TachycardiaFAERS: 8US FAERS
155TinnitusFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Urinary IncontinenceFAERS: 8US FAERS
157Vascular stent thrombosisFAERS: 8US FAERS
158VertigoFAERS: 8US FAERS
159WheezingFAERS: 8US FAERS
160AngioedemaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Back disorderFAERS: 7US FAERS
162DysphoniaFAERS: 7US FAERS
163Eye painFAERS: 7US FAERS
164Intestinal ObstructionFAERS: 7US FAERS
165Joint injuryFAERS: 7US FAERS
166Medication residueFAERS: 7US FAERS
167NephrolithiasisFAERS: 7US FAERS
168Oral painFAERS: 7US FAERS
169PallorFAERS: 7US FAERS
170PalpitationsFAERS: 7US FAERS
171Pancreatic carcinomaFAERS: 7US FAERS
172Peripheral swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
173Septic ShockFAERS: 7US FAERS
174Sudden deathFAERS: 7US FAERS
175Throat irritationFAERS: 7US FAERS
176Visual disturbanceFAERS: 7US FAERS
177Accidental overdoseFAERS: 6US FAERS
178AnorexiaFAERS: 6US FAERS
179Blood glucose increasedFAERS: 6US FAERS
180ChokingFAERS: 6US FAERS
181CholestasisFAERS: 6US FAERS
182Duodenal UlcerFAERS: 6US FAERS
183Ejection Fraction DecreasedFAERS: 6US FAERS
184FractureFAERS: 6US FAERS
185Impaired quality of lifeFAERS: 6US FAERS
186Impaired work abilityFAERS: 6US FAERS
187InfectionFAERS: 6US FAERS
188LymphadenopathyFAERS: 6US FAERS
189NervousnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Post procedural complicationFAERS: 6US FAERS
191Prescribed overdoseFAERS: 6US FAERS
192Rebound effectFAERS: 6US FAERS
193SinusitisFAERS: 6US FAERS
194Stevens-Johnson SyndromeFAERS: 6US FAERS
195nervous system disorderFAERS: 6US FAERS
196Acute kidney injuryFAERS: 5US FAERS
197ArteriosclerosisFAERS: 5US FAERS
198AsthmaFAERS: 5US FAERS
199BronchitisFAERS: 5US FAERS
200DeliriumFAERS: 5US FAERS
201Feeling ColdFAERS: 5US FAERS
202FlushingFAERS: 5US FAERS
203GangreneFAERS: 5US FAERS
204GlaucomaFAERS: 5US FAERS
205HypokinesiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Incorrect dose administeredFAERS: 5US FAERS
207NasopharyngitisFAERS: 5US FAERS
208Peripheral arterial occlusive diseaseFAERS: 5US FAERS
209Post procedural infectionFAERS: 5US FAERS
210ProteinuriaFAERS: 5US FAERS
211Serum SicknessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
212StressFAERS: 5US FAERS
213Toxic Epidermal NecrolysisFAERS: 5US FAERS
214Vascular ruptureFAERS: 5US FAERS
215Activities of daily living impairedFAERS: 4US FAERS
216AmyloidosisFAERS: 4US FAERS
217Anaphylactic shockFAERS: 4US FAERS
218AnosmiaFAERS: 4US FAERS
219Anti-insulin antibody increasedFAERS: 4US FAERS
220Basal cell carcinomaFAERS: 4US FAERS
221Blood cholesterol increasedFAERS: 4US FAERS
222Blood glucose decreasedFAERS: 4US FAERS
223Blood potassium increasedFAERS: 4US FAERS
224Blood urea increasedFAERS: 4US FAERS
225CataractFAERS: 4US FAERS
226CellulitisFAERS: 4US FAERS
227ColitisFAERS: 4US FAERS
228Disease recurrenceFAERS: 4US FAERS
229Drug prescribing errorFAERS: 4US FAERS
230Duodenal ulcer perforationFAERS: 4US FAERS
231DuodenitisFAERS: 4US FAERS
232EczemaFAERS: 4US FAERS
233EosinophiliaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Extra dose administeredFAERS: 4US FAERS
235Gamma-Glutamyltransferase IncreasedFAERS: 4US FAERS
236Gastrointestinal erosionFAERS: 4US FAERS
237HepatitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Ileal ulcerFAERS: 4US FAERS
239LaryngospasmFAERS: 4US FAERS
240Medication residue presentFAERS: 4US FAERS
241Mental impairmentFAERS: 4US FAERS
242Mental status changesFAERS: 4US FAERS
243Metastatic NeoplasmFAERS: 4US FAERS
244MonoplegiaFAERS: 4US FAERS
245Musculoskeletal chest painFAERS: 4US FAERS
246Night sweatsFAERS: 4US FAERS
247Peptic UlcerFAERS: 4US FAERS
248Phlebitis deepFAERS: 4US FAERS
249Polymyalgia RheumaticaFAERS: 4US FAERS
250Quality of life decreasedFAERS: 4US FAERS
251Rash erythematousFAERS: 4US FAERS
252Respiratory arrestFAERS: 4US FAERS
253Respiratory distressFAERS: 4US FAERS
254StomatitisFAERS: 4US FAERS
255Transaminases increasedFAERS: 4US FAERS
256Troponin increasedFAERS: 4US FAERS
257Unresponsive to stimuliFAERS: 4US FAERS
258Venous thrombosis limbFAERS: 4US FAERS
259Vitreous floatersFAERS: 4US FAERS
260Acute respiratory failureFAERS: 3US FAERS
261AlopeciaFAERS: 3US FAERS
262AphagiaFAERS: 3US FAERS
263Arterial stenosis limbFAERS: 3US FAERS
264Atrial FlutterFAERS: 3US FAERS
265Blood amylase increasedFAERS: 3US FAERS
266Blood lactate dehydrogenase increasedFAERS: 3US FAERS
267Blood potassium decreasedFAERS: 3US FAERS
268Bone marrow depressionFAERS: 3US FAERS
269Brain ContusionFAERS: 3US FAERS
270Cardiac TamponadeFAERS: 3US FAERS
271Cerebral disorderFAERS: 3US FAERS
272CholecystitisFAERS: 3US FAERS
273CholelithiasisFAERS: 3US FAERS
274Cholestatic liver injuryFAERS: 3US FAERS
275CoccidioidomycosisFAERS: 3US FAERS
276DiplopiaFAERS: 3US FAERS
277DiscomfortFAERS: 3US FAERS
278Disease ProgressionFAERS: 3US FAERS
279DiverticulumFAERS: 3US FAERS
280Documented hypersensitivity to administered drugFAERS: 3US FAERS
281Drug administration errorFAERS: 3US FAERS
282Dry skinFAERS: 3US FAERS
283DysuriaFAERS: 3US FAERS
284Embolic strokeFAERS: 3US FAERS
285Erectile dysfunctionFAERS: 3US FAERS
286Febrile NeutropeniaFAERS: 3US FAERS
287FlatulenceFAERS: 3US FAERS
288GastroenteritisFAERS: 3US FAERS
289Gastrointestinal carcinomaFAERS: 3US FAERS
290Gastrointestinal infectionFAERS: 3US FAERS
291HerniaFAERS: 3US FAERS
292HypophagiaFAERS: 3US FAERS
293HypoxiaFAERS: 3US FAERS
294ImmobileFAERS: 3US FAERS
295Incorrect drug administration durationFAERS: 3US FAERS
296Insulin C-peptide increasedFAERS: 3US FAERS
297Intentional product misuseFAERS: 3US FAERS
298LacerationFAERS: 3US FAERS
299Limb injuryFAERS: 3US FAERS
300Lipase increasedFAERS: 3US FAERS
301Mallory-Weiss SyndromeFAERS: 3US FAERS
302Nephrotic SyndromeFAERS: 3US FAERS
303OsteoporosisFAERS: 3US FAERS
304Personality ChangeFAERS: 3US FAERS
305Platelet aggregation decreasedFAERS: 3US FAERS
306PneumothoraxFAERS: 3US FAERS
307Post procedural myocardial infarctionFAERS: 3US FAERS
308PresyncopeFAERS: 3US FAERS
309Product dispensing errorFAERS: 3US FAERS
310Product dose omissionFAERS: 3US FAERS
311Product physical issueFAERS: 3US FAERS
312Product shape issueFAERS: 3US FAERS
313Product size issueFAERS: 3US FAERS
314Protein urine presentFAERS: 3US FAERS
315Pulmonary thrombosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Renal painFAERS: 3US FAERS
317RestlessnessFAERS: 3US FAERS
318Skin irritationFAERS: 3US FAERS
319Skin necrosisFAERS: 3US FAERS
320Spinal column stenosisFAERS: 3US FAERS
321Stroke in evolutionFAERS: 3US FAERS
322Temporal ArteritisFAERS: 3US FAERS
323Therapeutic response unexpectedFAERS: 3US FAERS
324ThrombocytosisFAERS: 3US FAERS
325Tooth LossFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
326Vascular stent occlusionFAERS: 3US FAERS
327Walking aid userFAERS: 3US FAERS
328Wrong technique in product usage processFAERS: 3US FAERS
329Abdominal tendernessFAERS: 2US FAERS
330Accidental exposure to productFAERS: 2US FAERS
331AngioplastyFAERS: 2US FAERS
332ApathyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
333AppendicitisFAERS: 2US FAERS
334AscitesFAERS: 2US FAERS
335AsphyxiaFAERS: 2US FAERS
336AsthenopiaFAERS: 2US FAERS
337Autoimmune hepatitisFAERS: 2US FAERS
338BedriddenFAERS: 2US FAERS
339Bladder NeoplasmFAERS: 2US FAERS
340Bladder neoplasm surgeryFAERS: 2US FAERS
341Blood count abnormalFAERS: 2US FAERS
342Blood iron decreasedFAERS: 2US FAERS
343Blood triglycerides increasedFAERS: 2US FAERS
344Blue Toe SyndromeFAERS: 2US FAERS
345Breast cancer recurrentFAERS: 2US FAERS
346CardiomegalyFAERS: 2US FAERS
347Cataract operationFAERS: 2US FAERS
348Catheter placementFAERS: 2US FAERS
349Cauda Equina SyndromeFAERS: 2US FAERS
350Clostridium difficile colitisFAERS: 2US FAERS
351Cold sweatFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
352Counterfeit product administeredFAERS: 2US FAERS
353Creatinine renal clearance decreasedFAERS: 2US FAERS
354CryingFAERS: 2US FAERS
355CyanosisFAERS: 2US FAERS
356Dark circles under eyesFAERS: 2US FAERS
357Dental cariesFAERS: 2US FAERS
358Depressed moodFAERS: 2US FAERS
359Diastolic dysfunctionFAERS: 2US FAERS
360Dieulafoy's vascular malformationFAERS: 2US FAERS
361Diffuse alveolar damageFAERS: 2US FAERS
362DyslaliaFAERS: 2US FAERS
363Electroencephalogram abnormalFAERS: 2US FAERS
364Electrolyte imbalanceFAERS: 2US FAERS
365Electromechanical dissociationFAERS: 2US FAERS
366Endoscopy upper gastrointestinal tract abnormalFAERS: 2US FAERS
367EructationFAERS: 2US FAERS
368Erythema MultiformeFAERS: 2US FAERS
369Facial paralysisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Fibrin D dimer increasedFAERS: 2US FAERS
371Gait inabilityFAERS: 2US FAERS
372Gastrointestinal PainFAERS: 2US FAERS
373Gastrointestinal perforationFAERS: 2US FAERS
374GingivitisFAERS: 2US FAERS
375GlomerulonephritisFAERS: 2US FAERS
376GoutFAERS: 2US FAERS
377Heat StrokeFAERS: 2US FAERS
378HepatotoxicityFAERS: 2US FAERS
379Histiocytosis haematophagicFAERS: 2US FAERS
380HungerFAERS: 2US FAERS
381HyperkeratosisFAERS: 2US FAERS
382Hypertensive emergencyFAERS: 2US FAERS
383IleusFAERS: 2US FAERS
384Impaired driving abilityFAERS: 2US FAERS
385Implantable defibrillator insertionFAERS: 2US FAERS
386Incisional herniaFAERS: 2US FAERS
387IncoherentFAERS: 2US FAERS
388IncontinenceFAERS: 2US FAERS
389Incorrect storage of drugFAERS: 2US FAERS
390Increased upper airway secretionFAERS: 2US FAERS
391InflammationFAERS: 2US FAERS
392Inhibitory drug interactionFAERS: 2US FAERS
393Intestinal PerforationFAERS: 2US FAERS
394Irritable Bowel SyndromeFAERS: 2US FAERS
395Joint stiffnessFAERS: 2US FAERS
396Leukocytoclastic vasculitisFAERS: 2US FAERS
397Limb discomfortFAERS: 2US FAERS
398Lung InjuryFAERS: 2US FAERS
399Lung consolidationFAERS: 2US FAERS
400LymphomaFAERS: 2US FAERS
401MalnutritionFAERS: 2US FAERS
402MenorrhagiaFAERS: 2US FAERS
403Mood swingsFAERS: 2US FAERS
404Multiple MyelomaFAERS: 2US FAERS
405Multiple allergiesFAERS: 2US FAERS
406MyositisFAERS: 2US FAERS
407Nerve injuryFAERS: 2US FAERS
408Neutrophil count decreasedFAERS: 2US FAERS
409Nuchal RigidityFAERS: 2US FAERS
410Oral candidiasisFAERS: 2US FAERS
411Pain of skinFAERS: 2US FAERS
412ParanoiaFAERS: 2US FAERS
413ParaplegiaFAERS: 2US FAERS
414PemphigusFAERS: 2US FAERS
415Pericardial effusionFAERS: 2US FAERS
416PeritonitisFAERS: 2US FAERS
417Photosensitivity allergic reactionFAERS: 2US FAERS
418Platelet aggregation abnormalFAERS: 2US FAERS
419PneumonitisFAERS: 2US FAERS
420PolyarthritisFAERS: 2US FAERS
421PregnancyFAERS: 2US FAERS
422Product appearance confusionFAERS: 2US FAERS
423Product solubility abnormalFAERS: 2US FAERS
424Product use issueFAERS: 2US FAERS
425QuadriparesisFAERS: 2US FAERS
426Renal massFAERS: 2US FAERS
427ReocclusionFAERS: 2US FAERS
428Respiratory tract infection fungalFAERS: 2US FAERS
429Reticulocyte count increasedFAERS: 2US FAERS
430Retinal Vascular DisorderFAERS: 2US FAERS
431Ruptured cerebral aneurysmFAERS: 2US FAERS
432Sexual DysfunctionFAERS: 2US FAERS
433ShockFAERS: 2US FAERS
434Skin WrinklingFAERS: 2US FAERS
435Skin lesionFAERS: 2US FAERS
436SneezingFAERS: 2US FAERS
437Splenic RuptureFAERS: 2US FAERS
438Subcutaneous EmphysemaFAERS: 2US FAERS
439Sudden Cardiac DeathFAERS: 2US FAERS
440Supraventricular tachycardiaFAERS: 2US FAERS
441Temperature intoleranceFAERS: 2US FAERS
442Therapeutic product ineffective for unapproved indicationFAERS: 2US FAERS
443Throat cancerFAERS: 2US FAERS
444Tooth InfectionFAERS: 2US FAERS
445Toxicity to various agentsFAERS: 2US FAERS
446Upper respiratory tract congestionFAERS: 2US FAERS
447Urethral ObstructionFAERS: 2US FAERS
448Urine output increasedFAERS: 2US FAERS
449Vascular stenosisFAERS: 2US FAERS
450Vasculitic rashFAERS: 2US FAERS
451VasculitisFAERS: 2US FAERS
452Ventricular FibrillationFAERS: 2US FAERS
453Vessel perforationFAERS: 2US FAERS
454Visual acuity reduced transientlyFAERS: 2US FAERS
455ADAMTS13 activity decreasedFAERS: 1US FAERS
456AbscessFAERS: 1US FAERS
457Accidental drug intake by childFAERS: 1US FAERS
458AcneFAERS: 1US FAERS
459Acquired gene mutationFAERS: 1US FAERS
460AgitationFAERS: 1US FAERS
461AkinesiaFAERS: 1US FAERS
462Altered visual depth perceptionFAERS: 1US FAERS
463AlveolitisFAERS: 1US FAERS
464AmaurosisFAERS: 1US FAERS
465Anaphylactoid ReactionFAERS: 1US FAERS
466Anastomotic stenosisFAERS: 1US FAERS
467Anastomotic ulcerFAERS: 1US FAERS
468AngerFAERS: 1US FAERS
469AngiodermatitisFAERS: 1US FAERS
470Angiogram pulmonary abnormalFAERS: 1US FAERS
471AnisocytosisFAERS: 1US FAERS
472Ankle FractureFAERS: 1US FAERS
473Anorectal discomfortFAERS: 1US FAERS
474Aortic occlusionFAERS: 1US FAERS
475AphoniaFAERS: 1US FAERS
476Aphthous StomatitisFAERS: 1US FAERS
477Arterial bypass operationFAERS: 1US FAERS
478Arterial therapeutic procedureFAERS: 1US FAERS
479Arterial thrombosisFAERS: 1US FAERS
480AspergillosisFAERS: 1US FAERS
481Aspiration pleural cavity abnormalFAERS: 1US FAERS
482Autoimmune thrombocytopeniaFAERS: 1US FAERS
483Bacterial sepsisFAERS: 1US FAERS
484Bilirubin conjugated increasedFAERS: 1US FAERS
485Bioptic eye surgeryFAERS: 1US FAERS
486Bladder painFAERS: 1US FAERS
487Bladder prolapseFAERS: 1US FAERS
488Blood alkaline phosphatase increasedFAERS: 1US FAERS
489Blood chloride increasedFAERS: 1US FAERS
490Blood cholesterol abnormalFAERS: 1US FAERS
491Blood glucose abnormalFAERS: 1US FAERS
492Blood glucose fluctuationFAERS: 1US FAERS
493Blood magnesium decreasedFAERS: 1US FAERS
494Blood pressure fluctuationFAERS: 1US FAERS
495Blood pressure inadequately controlledFAERS: 1US FAERS
496Blood sodium decreasedFAERS: 1US FAERS
497Blood viscosity decreasedFAERS: 1US FAERS
498Bone density decreasedFAERS: 1US FAERS
499Bone painFAERS: 1US FAERS
500BradyphreniaFAERS: 1US FAERS
501Bronchial ObstructionFAERS: 1US FAERS
502Bronchial secretion retentionFAERS: 1US FAERS
503BronchiectasisFAERS: 1US FAERS
504Bronchoalveolar lavage abnormalFAERS: 1US FAERS
505BronchospasmFAERS: 1US FAERS
506CarcinomaFAERS: 1US FAERS
507Cardiac FlutterFAERS: 1US FAERS
508Cardiac function test abnormalFAERS: 1US FAERS
509Cardiac procedure complicationFAERS: 1US FAERS
510Cardiovascular insufficiencyFAERS: 1US FAERS
511Carotid artery aneurysmFAERS: 1US FAERS
512Cartilage injuryFAERS: 1US FAERS
513Cell marker increasedFAERS: 1US FAERS
514Central nervous system function test abnormalFAERS: 1US FAERS
515Central nervous system lesionFAERS: 1US FAERS
516Cerebral PalsyFAERS: 1US FAERS
517Cerebral ThrombosisFAERS: 1US FAERS
518Cerebrovascular InsufficiencyFAERS: 1US FAERS
519Choking sensationFAERS: 1US FAERS
520CholangiostomyFAERS: 1US FAERS
521CholangitisFAERS: 1US FAERS
522Choroidal DetachmentFAERS: 1US FAERS
523Clostridium colitisFAERS: 1US FAERS
524ColectomyFAERS: 1US FAERS
525Colitis erosiveFAERS: 1US FAERS
526Complement factor C3 decreasedFAERS: 1US FAERS
527Complement factor decreasedFAERS: 1US FAERS
528Completed SuicideFAERS: 1US FAERS
529ConjunctivitisFAERS: 1US FAERS
530Contraindicated drug administeredFAERS: 1US FAERS
531Conversion disorderFAERS: 1US FAERS
532Coronary angioplastyFAERS: 1US FAERS
533Coronary artery insufficiencyFAERS: 1US FAERS
534Creatinine renal clearance increasedFAERS: 1US FAERS
535CytopeniaFAERS: 1US FAERS
536DermatitisFAERS: 1US FAERS
537DermatomyositisFAERS: 1US FAERS
538Device malfunctionFAERS: 1US FAERS
539Diabetes mellitus inadequate controlFAERS: 1US FAERS
540Diabetic NephropathyFAERS: 1US FAERS
541DiplegiaFAERS: 1US FAERS
542Disease complicationFAERS: 1US FAERS
543Drug DependenceFAERS: 1US FAERS
544Drug dispensing errorFAERS: 1US FAERS
545Drug effect incompleteFAERS: 1US FAERS
546Drug ineffective for unapproved indicationFAERS: 1US FAERS
547Drug level below therapeuticFAERS: 1US FAERS
548Drug metabolising enzyme decreasedFAERS: 1US FAERS
549Drug metabolising enzyme increasedFAERS: 1US FAERS
550Drug screen positiveFAERS: 1US FAERS
551Drug toxicityFAERS: 1US FAERS
552DysenteryFAERS: 1US FAERS
553DysphemiaFAERS: 1US FAERS
554DystoniaFAERS: 1US FAERS
555Ear discomfortFAERS: 1US FAERS
556Electrocardiogram abnormalFAERS: 1US FAERS
557Emotional disorderFAERS: 1US FAERS
558Endometrial disorderFAERS: 1US FAERS
559EnterocolitisFAERS: 1US FAERS
560Eosinophilic PneumoniaFAERS: 1US FAERS
561EpicondylitisFAERS: 1US FAERS
562Epidermolysis BullosaFAERS: 1US FAERS
563Epigastric discomfortFAERS: 1US FAERS
564EpilepsyFAERS: 1US FAERS
565ErysipelasFAERS: 1US FAERS
566Euphoric moodFAERS: 1US FAERS
567Expired product administeredFAERS: 1US FAERS
568ExsanguinationFAERS: 1US FAERS
569Eye laser surgeryFAERS: 1US FAERS
570Facial PainFAERS: 1US FAERS
571Failure to ThriveFAERS: 1US FAERS
572Feeding tube complicationFAERS: 1US FAERS
573Feeling jitteryFAERS: 1US FAERS
574Fibrin increasedFAERS: 1US FAERS
575Fixed drug eruptionFAERS: 1US FAERS
576Flank PainFAERS: 1US FAERS
577Fluid imbalanceFAERS: 1US FAERS
578Food AllergyFAERS: 1US FAERS
579Foreign body aspirationFAERS: 1US FAERS
580Frustration tolerance decreasedFAERS: 1US FAERS
581Full blood count decreasedFAERS: 1US FAERS
582Gallbladder painFAERS: 1US FAERS
583Gastric FistulaFAERS: 1US FAERS
584Gastric infectionFAERS: 1US FAERS
585Gastroenteritis norovirusFAERS: 1US FAERS
586Gastrointestinal angiodysplasia haemorrhagicFAERS: 1US FAERS
587Gastrointestinal endoscopic therapyFAERS: 1US FAERS
588Gene mutation identification test positiveFAERS: 1US FAERS
589Glaucoma surgeryFAERS: 1US FAERS
590Glioblastoma MultiformeFAERS: 1US FAERS
591GlossitisFAERS: 1US FAERS
592Gluten sensitivityFAERS: 1US FAERS
593Granulomatosis with polyangiitisFAERS: 1US FAERS
594Haptoglobin DecreasedFAERS: 1US FAERS
595Head discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
596Hearing disabilityFAERS: 1US FAERS
597Hepatitis CFAERS: 1US FAERS
598HepatomegalyFAERS: 1US FAERS
599HepatosplenomegalyFAERS: 1US FAERS
600Hip swellingFAERS: 1US FAERS
601HostilityFAERS: 1US FAERS
602HydrocephalusFAERS: 1US FAERS
603HyperchlorhydriaFAERS: 1US FAERS
604HyperpyrexiaFAERS: 1US FAERS
605HypersomniaFAERS: 1US FAERS
606Hypertensive heart diseaseFAERS: 1US FAERS
607Hypertrophic CardiomyopathyFAERS: 1US FAERS
608Hypertrophy of tongue papillaeFAERS: 1US FAERS
609HyperventilationFAERS: 1US FAERS
610Hypoaesthesia facialFAERS: 1US FAERS
611Hypocoagulable stateFAERS: 1US FAERS
612HyporeflexiaFAERS: 1US FAERS
613HypoventilationFAERS: 1US FAERS
614HysterectomyFAERS: 1US FAERS
615Iatrogenic injuryFAERS: 1US FAERS
616Iliac artery occlusionFAERS: 1US FAERS
617Iliac artery stenosisFAERS: 1US FAERS
618Impaired gastric emptyingFAERS: 1US FAERS
619Inappropriate schedule of drug administrationFAERS: 1US FAERS
620Incorrect drug dosage form administeredFAERS: 1US FAERS
621Incorrect route of drug administrationFAERS: 1US FAERS
622Infectious pleural effusionFAERS: 1US FAERS
623InfestationFAERS: 1US FAERS
624Infrequent bowel movementsFAERS: 1US FAERS
625Initial insomniaFAERS: 1US FAERS
626Injection site bruisingFAERS: 1US FAERS
627Insulin C-peptide decreasedFAERS: 1US FAERS
628Intercepted drug prescribing errorFAERS: 1US FAERS
629Intestinal resectionFAERS: 1US FAERS
630IritisFAERS: 1US FAERS
631Jejunal ulcerFAERS: 1US FAERS
632Kernig's signFAERS: 1US FAERS
633Lack of spontaneous speechFAERS: 1US FAERS
634LaryngitisFAERS: 1US FAERS
635Left Ventricular HypertrophyFAERS: 1US FAERS
636LeukocytosisFAERS: 1US FAERS
637Ligament ruptureFAERS: 1US FAERS
638Limb crushing injuryFAERS: 1US FAERS
639Lobar PneumoniaFAERS: 1US FAERS
640Loss of personal independence in daily activitiesFAERS: 1US FAERS
641Low density lipoprotein increasedFAERS: 1US FAERS
642Lower Urinary Tract SymptomsFAERS: 1US FAERS
643Lupus-like syndromeFAERS: 1US FAERS
644LymphopeniaFAERS: 1US FAERS
645Macular detachmentFAERS: 1US FAERS
646Malignant neoplasm progressionFAERS: 1US FAERS
647MastitisFAERS: 1US FAERS
648MeningiomaFAERS: 1US FAERS
649Meniscus injuryFAERS: 1US FAERS
650Mesenteric arterial occlusionFAERS: 1US FAERS
651MesotheliomaFAERS: 1US FAERS
652Metastases to adrenalsFAERS: 1US FAERS
653Migraine with AuraFAERS: 1US FAERS
654Mitral Valve StenosisFAERS: 1US FAERS
655Mixed liver injuryFAERS: 1US FAERS
656Mononeuropathy MultiplexFAERS: 1US FAERS
657MonoparesisFAERS: 1US FAERS
658Mouth swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
659Mucosal erosionFAERS: 1US FAERS
660Muscle tightnessFAERS: 1US FAERS
661Muscular DystrophyFAERS: 1US FAERS
662Musculoskeletal discomfortFAERS: 1US FAERS
663Mycosis FungoidesFAERS: 1US FAERS
664MyelofibrosisFAERS: 1US FAERS
665MyopathyFAERS: 1US FAERS
666NecrosisFAERS: 1US FAERS
667NephritisFAERS: 1US FAERS
668NephrocalcinosisFAERS: 1US FAERS
669Nerve Root CompressionFAERS: 1US FAERS
670NeuritisFAERS: 1US FAERS
671Neutropenic sepsisFAERS: 1US FAERS
672No adverse effectFAERS: 1US FAERS
673NocturiaFAERS: 1US FAERS
674Non-cardiac chest painFAERS: 1US FAERS
675Nuclear magnetic resonance imaging abdominal abnormalFAERS: 1US FAERS
676NystagmusFAERS: 1US FAERS
677Ocular discomfortFAERS: 1US FAERS
678Ocular vascular disorderFAERS: 1US FAERS
679Oculomucocutaneous syndromeFAERS: 1US FAERS
680OligospermiaFAERS: 1US FAERS
681OliguriaFAERS: 1US FAERS
682Otitis MediaFAERS: 1US FAERS
683OverweightFAERS: 1US FAERS
684Pancreatic FistulaFAERS: 1US FAERS
685PanniculitisFAERS: 1US FAERS
686PapuleFAERS: 1US FAERS
687ParesisFAERS: 1US FAERS
688Pathological fractureFAERS: 1US FAERS
689Pelvic massFAERS: 1US FAERS
690Peptic Ulcer PerforationFAERS: 1US FAERS
691Perforated ulcerFAERS: 1US FAERS
692PeriarthritisFAERS: 1US FAERS
693Peripheral nerve palsyFAERS: 1US FAERS
694Pharyngeal swellingFAERS: 1US FAERS
695PharyngitisFAERS: 1US FAERS
696Pharyngolaryngeal PainFAERS: 1US FAERS
697PhimosisFAERS: 1US FAERS
698PhotophobiaFAERS: 1US FAERS
699Platelet aggregation inhibitionFAERS: 1US FAERS
700Platelet aggregationFAERS: 1US FAERS
701Pleural mesothelioma malignant recurrentFAERS: 1US FAERS
702PleurisyFAERS: 1US FAERS
703Pleuritic painFAERS: 1US FAERS
704Pneumatosis intestinalisFAERS: 1US FAERS
705Pneumocystis jiroveci pneumoniaFAERS: 1US FAERS
706PoikilocytosisFAERS: 1US FAERS
707Polyarteritis NodosaFAERS: 1US FAERS
708PolymyositisFAERS: 1US FAERS
709PolyneuropathyFAERS: 1US FAERS
710Poor peripheral circulationFAERS: 1US FAERS
711Poor quality sleepFAERS: 1US FAERS
712Post procedural sepsisFAERS: 1US FAERS
713Post-Traumatic Stress DisorderFAERS: 1US FAERS
714Post-traumatic neck syndromeFAERS: 1US FAERS
715Prerenal failureFAERS: 1US FAERS
716Prescription form tamperingFAERS: 1US FAERS
717Primary amyloidosisFAERS: 1US FAERS
718Procedural complicationFAERS: 1US FAERS
719Product administration errorFAERS: 1US FAERS
720Product availability issueFAERS: 1US FAERS
721Product design issueFAERS: 1US FAERS
722Product label issueFAERS: 1US FAERS
723Product label on wrong productFAERS: 1US FAERS
724Product supply issueFAERS: 1US FAERS
725Prostate examination abnormalFAERS: 1US FAERS
726Prothrombin level decreasedFAERS: 1US FAERS
727Psoas AbscessFAERS: 1US FAERS
728Psychiatric symptomFAERS: 1US FAERS
729Pulmonary HypertensionFAERS: 1US FAERS
730Pulmonary Valve StenosisFAERS: 1US FAERS
731Pulmonary congestionFAERS: 1US FAERS
732Pulmonary granulomaFAERS: 1US FAERS
733Pustular psoriasisFAERS: 1US FAERS
734Pyoderma GangrenosumFAERS: 1US FAERS
735PyomyositisFAERS: 1US FAERS
736QuadriplegiaFAERS: 1US FAERS
737Radiation injuryFAERS: 1US FAERS
738Reaction to drug excipientsFAERS: 1US FAERS
739Reaction to excipientFAERS: 1US FAERS
740Recalled product administeredFAERS: 1US FAERS
741Rectal ProlapseFAERS: 1US FAERS
742Red reflex abnormalFAERS: 1US FAERS
743Renal artery occlusionFAERS: 1US FAERS
744Renal cystFAERS: 1US FAERS
745Respiratory DepressionFAERS: 1US FAERS
746Retinal aneurysmFAERS: 1US FAERS
747Retinal infarctionFAERS: 1US FAERS
748Retinal vascular thrombosisFAERS: 1US FAERS
749Retroperitoneal fibrosisFAERS: 1US FAERS
750Right ventricular systolic pressure increasedFAERS: 1US FAERS
751SarcoidosisFAERS: 1US FAERS
752ScabFAERS: 1US FAERS
753SciaticaFAERS: 1US FAERS
754SclerodermaFAERS: 1US FAERS
755ScreamingFAERS: 1US FAERS
756Sedation complicationFAERS: 1US FAERS
757Senile dementiaFAERS: 1US FAERS
758Shunt aneurysmFAERS: 1US FAERS
759Silent myocardial infarctionFAERS: 1US FAERS
760Sinus ArrhythmiaFAERS: 1US FAERS
761Sinus TachycardiaFAERS: 1US FAERS
762Sinus bradycardiaFAERS: 1US FAERS
763Sinus headacheFAERS: 1US FAERS
764Skin ErosionFAERS: 1US FAERS
765Skin noduleFAERS: 1US FAERS
766Sleep ParalysisFAERS: 1US FAERS
767Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
768Slow response to stimuliFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
769Small cell lung cancer metastaticFAERS: 1US FAERS
770Small intestine carcinomaFAERS: 1US FAERS
771Spinal column injuryFAERS: 1US FAERS
772Spinal cord infectionFAERS: 1US FAERS
773SplenectomyFAERS: 1US FAERS
774SplenomegalyFAERS: 1US FAERS
775Squamous cell carcinomaFAERS: 1US FAERS
776StaringFAERS: 1US FAERS
777Status EpilepticusFAERS: 1US FAERS
778StenosisFAERS: 1US FAERS
779Stent malfunctionFAERS: 1US FAERS
780Subclavian artery embolismFAERS: 1US FAERS
781Suicide attemptFAERS: 1US FAERS
782SunburnFAERS: 1US FAERS
783Systemic mycosisFAERS: 1US FAERS
784Tardive DyskinesiaFAERS: 1US FAERS
785Teeth brittleFAERS: 1US FAERS
786Tendon discomfortFAERS: 1US FAERS
787Therapeutic procedureFAERS: 1US FAERS
788Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
789Therapy non-responderFAERS: 1US FAERS
790Therapy regimen changedFAERS: 1US FAERS
791ThirstFAERS: 1US FAERS
792ThoracotomyFAERS: 1US FAERS
793ToothacheFAERS: 1US FAERS
794TrismusFAERS: 1US FAERS
795Trousseau's syndromeFAERS: 1US FAERS
796Tryptase increasedFAERS: 1US FAERS
797TuberculosisFAERS: 1US FAERS
798Ultrasound antenatal screenFAERS: 1US FAERS
799UnemploymentFAERS: 1US FAERS
800Urinary bladder polypFAERS: 1US FAERS
801Urine protein/creatinine ratio abnormalFAERS: 1US FAERS
802Uterine CancerFAERS: 1US FAERS
803UveitisFAERS: 1US FAERS
804Vascular bypass dysfunctionFAERS: 1US FAERS
805Vascular graft complicationFAERS: 1US FAERS
806Vascular procedure complicationFAERS: 1US FAERS
807Vascular purpuraFAERS: 1US FAERS
808Vascular stent restenosisFAERS: 1US FAERS
809Vascular stent stenosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
810Venous InjuryFAERS: 1US FAERS
811Venous ThrombosisFAERS: 1US FAERS
812Ventricular arrhythmiaFAERS: 1US FAERS
813Vocal Cord ParalysisFAERS: 1US FAERS
814Vulvovaginal mycotic infectionFAERS: 1US FAERS
815Water IntoxicationFAERS: 1US FAERS
816Wheelchair userFAERS: 1US FAERS
817Williams SyndromeFAERS: 1US FAERS
818Wound InfectionFAERS: 1US FAERS
819Wrong drug administeredFAERS: 1US FAERS
820colonoscopyFAERS: 1US FAERS
821effusionFAERS: 1US FAERS
822heart rateFAERS: 1US FAERS
823FormicationCanada Vigilance: 1Canada Vigilance
824Gastric DilatationCanada Vigilance: 1Canada Vigilance
825Serum sickness-like reactionCanada Vigilance: 1Canada Vigilance
826Therapeutic response changedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.